Skip to main content
. Author manuscript; available in PMC: 2020 Dec 15.
Published in final edited form as: Nat Genet. 2020 Jun 15;52(7):680–691. doi: 10.1038/s41588-020-0637-y

Table 6 |.

Polygenic risk scores and non-vascular outcomes

Outcometype Outcome T2D PRS decile n Cases n Controls OR 95%CI lower 95%CI upper P P for linear trend
Non-vascular Retinopathy 0–10% 792 4,533 1.00 Ref Ref - 3.1E-32
10–20% 832 4,533 1.08 0.97 1.20 0.158
20–30% 795 4,533 1.05 0.94 1.17 0.364
30–40% 852 4,533 1.14 1.02 1.26 0.019
40–50% 814 4,533 1.08 0.97 1.20 0.152
50–60% 891 4,533 1.20 1.08 1.33 6.8E-04
60–70% 901 4,533 1.25 1.13 1.39 3.1E-05
70–80% 936 4,533 1.30 1.17 1.45 6.8E-07
80–90% 1,031 4,533 1.47 1.33 1.63 2.2E-13
90–100% 1,069 4,533 1.59 1.44 1.77 4.2E-19
Chronic kidney 0–10% 3,446 3,391 1.00 Ref Ref - 7.3E-06
disease 10–20% 3,490 3,391 1.03 0.93 1.15 0.508
20–30% 3,439 3,391 1.04 0.94 1.14 0.488
30–40% 3,463 3,391 1.05 0.95 1.16 0.323
40–50% 3,370 3,391 1.04 0.95 1.14 0.409
50–60% 3,362 3,391 1.07 0.97 1.17 0.166
60–70% 3,389 3,391 1.07 0.98 1.17 0.129
70–80% 3,285 3,391 1.07 0.98 1.17 0.121
80–90% 3,373 3,391 1.07 0.98 1.16 0.151
90–100% 3,326 3,391 1.16 1.07 1.26 5.9E-04
Neuropathy 0–10% 2,176 3,814 1.00 Ref Ref - 7.9E-08
10–20% 2,193 3,814 1.03 0.96 1.11 0.436
20–30% 2,217 3,814 1.07 0.99 1.15 0.075
30–40% 2,218 3,814 1.06 0.99 1.15 0.110
40–50% 2,217 3,814 1.05 0.98 1.13 0.192
50–60% 2,293 3,814 1.11 1.03 1.20 0.006
60–70% 2,261 3,814 1.10 1.02 1.18 0.014
70–80% 2,253 3,814 1.10 1.02 1.19 0.009
80–90% 2,265 3,814 1.11 1.03 1.19 0.007
90–100% 2,377 3,814 1.21 1.12 1.30 9.7E-07

Genome-wide polygenic risk scores (gPRS) for T2D were generated in the MVP participants of European ancestry with T2D by calculating a linear combination of weights derived from the Europeans in the DIAMANTE Consortium using the prune and threshold method in PRSice-2 software (pruning r2 = 0.8, P = 0.05). The gPRSs were divided into deciles and the risk of T2D-related non-vascular outcomes was assessed using a logistic regression model using the lowest decile (0–10%) as the reference category, together with the potential confounding factors of age, gender, and the first 10 PCs of European ancestry. The decile-specific P-values are shown in the column labeled P. In a separate logistic regression analysis, the continuous PRS was set as the dependent variable together with age, gender, and the first 10 PCs, and the P-value for linear trend is shown in the column labeled P for linear trend. For chronic kidney disease, a CKD PRS (from CKDgen consortium) is included in the regression model as an additional covariate. T2D, type 2 diabetes; PRS, polygenic risk score; n Cases, number of cases with the respective non-vascular outcome; n Controls, number of unaffected controls for the respective non-vascular outcome; OR, odds ratio; CI, confidence interval.